Phase 3 registrational trials evaluating petosemtamab in combination with pembrolizumab in 1L and petosemtamab monotherapy in 2/3L r/m HNSCC enrolling…
Company to host a conference call tomorrow at 8:00 a.m. ET NEWTON, Mass., Oct. 30, 2024 /PRNewswire/ -- Karyopharm Therapeutics…
"Discover High-Growth Opportunities Across Leading Sectors, With BCC Research Highlighting Industries Primed for Up to 20% Annual Returns" BOSTON, Oct.…
The VELA Mammography Chair is the latest and most significant development in women's imaging in the U.S. TAMPA, FL /…
Beauty-Stem Biomedical continues to make strides in preventive medicine, advancing the science of stem cell nutrition to prevent and combat…
WILMINGTON, Del., Oct. 30, 2024 /PRNewswire/ -- Geneyx Inc. a pioneering global company for an AI Multi-Omics analysis system, and [Pittsburgh,…
Helix reveals new research developments in a wide range of therapeutic areas at the American Society of Human Genetics 2024…
Life sciences, academic medical centers, health systems, and research institutes can gain insights into diseases and their impact on patients…
STOCKHOLM, SE / ACCESSWIRE / October 30, 2024 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical…
NEW YORK, Oct. 29, 2024 /PRNewswire/ -- Report with market evolution powered by AI - The global sperm separation devices…